Risks of Iodine Excess
Endocrine Reviews · 22.11.2024 · 45 (6) · 858-879
DOI: 10.1210/endrev/bnae019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 13.06.2024. Verfasst von Seo Young Sohn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang 10475, South Korea. Hauptthemen laut MEDLINE: Iodine. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 210 Literaturangaben. Gefördert von: CSRD VA, U.S. Department of Veterans Affairs, Clinical Science Research & Development Merit Award.
Abstract (Originalsprache)
Iodine is a micronutrient that is required for thyroid hormone synthesis. The iodide cycle in thyroid hormone synthesis consists of a series of transport, oxidation, organification, and binding/coupling steps in thyroid follicular cells. Common sources of iodine include the consumption of an iodine-rich diet or iodine-fortified foods, the administration of amiodarone, iodine-containing supplements, or iodinated contrast media, and other miscellaneous sources. Methods to assess population iodine status include the measurement of urinary iodine concentrations, blood thyroglobulin levels, prevalence of elevated neonatal thyrotropin levels, and thyroid volume. Although excessive iodine intake or exposure is generally well tolerated, an acute iodine load may result in thyroid dysfunction (hypothyroidism or hyperthyroidism) in certain susceptible individuals due to the failure to escape from the Wolff–Chaikoff effect and to the Jod–Basedow phenomenon, respectively. In this review, we discuss the associations between excessive iodine intake or exposure, with particular focus on iodinated contrast media as a common source of excess iodine in health care settings, and risks of incident thyroid dysfunction. We also summarize the risks of iodine excess in vulnerable populations and review current guidelines regarding the screening and monitoring of iodinated contrast–induced thyroid dysfunction. Finally, we discuss the long-term potential nonthyroidal health risks associated with iodine excess and suggest the need for more data to define safe upper limits for iodine intake, particularly in high-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang 10475, South Korea.
- Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
- Hakubi Center, Kyoto University, Kyoto 606-8501, Japan.
- Division of Nephrology, Department of Medicine, Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles 90095, CA, USA.
- Division of Nephrology, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles 90073, CA, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles 90095, CA, USA.
ORCID-Profile: Seo Young Sohn, Kosuke Inoue, Connie M Rhee, Angela M Leung
Förderung
- CSRD VA
- U.S. Department of Veterans Affairs
- Clinical Science Research & Development Merit Award
Zitieren
APA
Sohn, S. Y., Inoue, K., Rhee, C. M., & Leung, A. M. (2024). Risks of Iodine Excess. Endocrine Reviews, 45(6), 858-879. https://doi.org/10.1210/endrev/bnae019
Vancouver
Sohn SY, Inoue K, Rhee CM, Leung AM. Risks of Iodine Excess. Endocrine Reviews. 2024;45(6):858-879. doi:10.1210/endrev/bnae019
BibTeX
@article{Sohn2024,
author = {Sohn, Seo Young and Inoue, Kosuke and Rhee, Connie M and Leung, Angela M},
title = {Risks of Iodine Excess},
journal = {Endocrine Reviews},
year = {2024},
volume = {45},
number = {6},
pages = {858--879},
doi = {10.1210/endrev/bnae019}
}
EUVIMED